Showing 361-370 of 2192 results for "".
Video Case Solution: Glomus Jugulare
https://practicalneurology.com/diseases-diagnoses/headache-pain/video-case-solution-glomus-jugulare/30579/Last month's case presented a 41-year-old woman with a one-year history of tinnitus and left otalgia.Recent Advances in the Medical Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/recent-advances-in-the-medical-treatment-of-epilepsy/30795/From agents in early clinical trials to relatively recent approvals, multiple treatments may improve the care of common and rare forms of epilepsy.Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-2025-drug-device-approvals/54790/A quick reference for the drugs and devices for neurologic conditions that received approval or clearance notice from the Food and Drug Administration last year.Sleep Disorders: Special Challenges in Female Patients
https://practicalneurology.com/diseases-diagnoses/sleep/1109_02-php/30871/Some sleep problems occur with great frequency in women, while others present with greater intensity. Here's what you need to know.The Penalty Era: The Next Phase in Medicine
https://practicalneurology.com/archives/2015-june/the-penalty-era-the-next-phase-in-medicine/30549/New proposed rule changes spell an uncertain future for the Meaningful Use program.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31196/Intravenous thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke has been FDA approved for over a decade, yet its status as the standard of care within the three-hour window remains debated among neurologists. Critics often cite the original NINDS tPA trials' limited sample
- Vascular Clinichttps://practicalneurology.com/diseases-diagnoses/stroke/PN0505Vascular-pdf/31460/Intracranial stenosis, responsible for 10-15% of all strokes and more prevalent among non-Caucasian populations such as Asians and African Americans, remains a critical yet under-researched area in vascular neurology. Historically, the medical management of intracranial stenosis lacked robust prospe
- Epilepsy Care: Can We Succeed with Monotherapy?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0405CvrStry-pdf/31461/Advancements and Challenges in Antiepileptic Drug MonotherapyIn the realm of epilepsy management, achieving seizure freedom remains the primary goal for neurologists and patients alike. Approximately 60-70% of newly diagnosed epilepsy patients achieve control with a single antiepileptic drug (AED),
Neuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.